142 related articles for article (PubMed ID: 15816892)
1. Functional status and quality of life in patients surviving 10 years after lung transplantation.
Rutherford RM; Fisher AJ; Hilton C; Forty J; Hasan A; Gould FK; Dark JH; Corris PA
Am J Transplant; 2005 May; 5(5):1099-104. PubMed ID: 15816892
[TBL] [Abstract][Full Text] [Related]
2. Determinants of health utility in lung and heart-lung transplant recipients.
Singer LG; Gould MK; Tomlinson G; Theodore J
Am J Transplant; 2005 Jan; 5(1):103-9. PubMed ID: 15636617
[TBL] [Abstract][Full Text] [Related]
3. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
4. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
Hadjiliadis D; Davis RD; Palmer SM
Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
[TBL] [Abstract][Full Text] [Related]
5. Exhaled nitric oxide after lung transplantation: impact of the native lung.
Verleden GM; Dupont LJ; Delcroix M; Van Raemdonck D; Vanhaecke J; Lerut T; Demedts M
Eur Respir J; 2003 Mar; 21(3):429-32. PubMed ID: 12661996
[TBL] [Abstract][Full Text] [Related]
6. Observational study of lung transplant recipients surviving 20 years.
Sithamparanathan S; Thirugnanasothy L; Clark S; Dark JH; Fisher AJ; Gould KF; Hasan A; Lordan JL; Meachery G; Parry G; Corris PA
Respir Med; 2016 Aug; 117():103-8. PubMed ID: 27492519
[TBL] [Abstract][Full Text] [Related]
7. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
9. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive investigations for the early detection of chronic airways dysfunction following lung transplantation.
Cook RC; Fradet G; Müller NL; Worsely DF; Ostrow D; Levy RD
Can Respir J; 2003 Mar; 10(2):76-83. PubMed ID: 12687027
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation.
Künsebeck HW; Kugler C; Fischer S; Simon AR; Gottlieb J; Welte T; Haverich A; Strueber M
Prog Transplant; 2007 Jun; 17(2):136-41. PubMed ID: 17624136
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of laparoscopic Nissen fundoplication after pediatric lung or heart-lung transplantation: should this be the standard?
Zheng C; Kane TD; Kurland G; Irlano K; Spahr J; Potoka DA; Weardon PD; Morell VO
Surg Endosc; 2011 Jan; 25(1):249-54. PubMed ID: 20585963
[TBL] [Abstract][Full Text] [Related]
15. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
Fisher AJ; Wardle J; Dark JH; Corris PA
J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
[TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival.
Brugière O; Pessione F; Thabut G; Mal H; Jebrak G; Lesèche G; Fournier M
Chest; 2002 Jun; 121(6):1883-9. PubMed ID: 12065353
[TBL] [Abstract][Full Text] [Related]
17. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
18. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
19. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
[TBL] [Abstract][Full Text] [Related]
20. The impact of bronchiolitis obliterans on late morbidity and mortality after single and bilateral lung transplantation for pulmonary hypertension.
Sundaresan S
Semin Thorac Cardiovasc Surg; 1998 Apr; 10(2):152-9. PubMed ID: 9620464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
